OTC · Drug Manufacturers - Specialty & Generic

Halo Collective Inc. (HCANF) Stock

$0.00 OTC: HCANF Healthcare

Founded in 2016 and headquartered in Toronto, Canada, Halo Collective Inc. is a vertically integrated cannabis company.

Valuation

MetricValue
Price$0.00
Market Cap$15081
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-10.55
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-254.55%
ROA-147.37%
ROCE-80.61%
Gross Margin-136.00%
Operating Margin-140.00%
Net Margin-336.00%
Debt/Equity0.55
Current Ratio1.36

Annual Financials (USD)

Metric20182019202020212022
Revenue$11.0M$28.0M$22.0M$36.0M$25.0M
Operating Profit$-10.0M$-22.0M$-21.0M$-42.0M$-35.0M
Net Profit$-14.0M$-28.0M$-41.0M$-95.0M$-84.0M
EPS$-2200.00$-1400.00$-727.00$-83.62$-10.55
Op Margin-93.1%-76.6%-98.0%-115.3%-142.2%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$19.0M$42.0M$88.0M$105.0M$57.0M
Total Liabilities$5.0M$18.0M$28.0M$38.0M$27.0M
Cash$1.0M$4.0M$3.0M$2.0M$1.0M
Borrowings$1.0M$10.0M$19.0M$25.0M$18.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-12.0M$-15.0M$-10.0M$-35.0M$-12.0M
Investing Cash Flow$-7.0M$-4.0M$-6.0M$-3.0M$-1.0M
Financing Cash Flow$-12.0M$-1.0M$0$0$-2.0M
Net Cash Flow$1.0M$5.0M$-2.0M$-2.0M$-1.0M
Free Cash Flow$-16.0M$-17.0M$-14.0M$-38.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.23
FCF Yield-92093.89%
Quick Ratio0.55
Interest Coverage-11.11
Return 1Y0.00%
Return 3Y-99.38%
Return 5Y

Ownership

Insiders Held1.53%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Captrust Financial Advisors52022-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AOLSAeolus Pharmaceuticals, Inc. $0.00 0.00 $15209 0.00%
CNTTQCannTrust Holdings Inc. $0.00 0.00 $1412 0.00%
DZCADrazCanna, Inc. $0.01 +0.00% -1.57 $129345 0.00%
FDBHFounders Bay Holdings $0.00 0.00 $25036 0.00%
LOWLFLowell Farms Inc. $0.00 0.00 $1815 0.00%

About Halo Collective Inc.

Founded in 2016 and headquartered in Toronto, Canada, Halo Collective Inc. is a vertically integrated cannabis company. (The firm adopted its current name in January 2021, previously operating as Halo Labs Inc.) Its core operations involve cultivating, manufacturing, and distributing cannabis products throughout the United States. The company specializes in growing, extracting, and processing various forms of cannabis, including flowers, oils, and concentrates. Beyond these, Halo Collective also offers a range of edible products, such as cannabis-infused gummies and a distinctive syrup beverage, available in California and Oregon. Halo Collective markets both its own branded products—like Hush, Mojave, and Exhale—and private label items, primarily selling its cannabis offerings to dispensaries. Its clientele includes licensed retailers and wholesalers. The company also maintains significant collaborations, including a strategic partnership with High Tide Inc. and an alliance with OG DNA Genetics Inc. focused on developing cannabis genetics in Oregon.

Halo Collective Inc. (HCANF) stock trades at $0.00 with a market capitalization of $15081. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Halo Collective Inc. generates a return on equity (ROE) of -254.55%, return on capital employed of -80.61%, an operating margin of -140.00%, a net profit margin of -336.00%.

Official website: www.haloco.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides